Replies to post #619054 on NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

My understanding is that usually when one optimizes something, one is testing a completed product to perfect its function and effectiveness. This statement is new. Also, does the fact that they consider Flaskworks as the centerpiece toward scale-up for potential commercial operations mean they intend or hope to have Flaskworks in place in anticipation of an approval, and at that time?

The Company’s wholly owned subsidiary, Flaskworks, is continuing its development work to optimize a system for closed and automated manufacturing of DCVax-L products, including optimizing yields. The Company views this as a centerpiece of efforts toward scale-up for potential commercial operations.